BIOMM S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14 BRL | -14.43% |
|
-14.63% | +142.21% |
| 05-16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOMM S.A. | Bio Therapeutic Drugs | -14.43% | -14.63% | +142.21% | +155.01% | +120.13% | 339M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIOM3 Stock
- Charts Biomm S.A.
- Comparison Chart
